Human Therapeutic Mabs

 

We have specific ELISA kits to measure active therapeutic humanized antibodies (Xolair, Humira, Rituximab, and Herceptin) in human and animals. Antibodies to therapeutics drugs (HADA/HAMA) after administration into humans can also be detected and measured using ELISA kits


.....Read More.
IgE mabs (Xolair) (Omalizumab)
TNF-A mabs (Humira) (Adalimumab)
CD-20 mabs (Rituximab) (Rituxan)
Her2/Errb2 mabs (Herceptin) (Trastuzumab)

 

Catalog# Product Description Product Type Size
200-200-HAH Human Anti-Human IgG (HAHA) ELISA kit, 96 tests Kit 1 kit
200-205-HAM Human Anti-Mouse IgG (HAMA) ELISA kit, 96 tests Kit 1 kit
200-210-RAG Rituximab/Rituxan/Anti-CD20 (Active) ELISA Kit (Human/mouse/rat),96 tests Kit 1 kit
200-245-HAM Human Anti-Rituximab/Rituxan (HADA/HAMA) IgG ELISA kit for human, 96 tests Kit 1 kit
200-300-ADG Humira/Adalimumab (Human Anti-TNF-alpha) ELISA Kit for dog, 96 tests Kit 1 kit
200-310-ADG Humira/Adalumumab (Human Anti-TNF-alpha) ELISA Kit for human, 96 tests Kit 1 kit
200-310-AHG Humira/Adalimumab (Human Anti-TNF-alpha) ELISA Kit for human, 96 tests Kit 1 kit
200-320-ADG Human Anti-Humira/Adalimumab (Human Anti-TNF-alpha) IgG ELISA Kit, 96 tests Kit 1 kit
200-320-AHG Human Anti-Humira/Adalimumab (Human Anti-TNF-alpha) ELISA Kit for human, 96 tests Kit 1 kit
200-330-TNF Human TNF-alpha ELISA Kit, 96 tests Kit 1 kit
200-410-XLG Xolair/Omalizumab ELISA Kit for human, 96 tests Kit 1 kit
200-420-XLG Human Anti-Xolair/Omalizumab Antibody ELISA Kit for human, 96 tests Kit 1 kit
200-430-XET Human IgE (total) ELISA Kit for Xolair-treated samples, 96 tests Kit 1 kit
200-440-XEF Human IgE (Free; Xolair unbound) ELISA Kit for Xolair-treated samples, 96 tests Kit 1 kit
200-510-HLG Herceptin/Trasuzumab ELISA Kit for human, 96 tests Kit 1 kit
200-520-HAG Human Anti-Herceptin/Trasuzumab Antibody (HAHA) Kit 96 tests Kit 1 kit
200-530-HER Her2/neu/Erbb2/CD340 protein ELISA kit, 96 tests Kit 1 kit
200-600-HRH Human Anti-Her2 Protein (ECD) IgG ELISA kit for Her2 vaccine, 96 tests, Quantitative Kit 1 Kit
200-610-HRM Human Anti-Her2 Protein (ECD) IgM ELISA kit for Her2 vaccine, 96 tests, Quantitative Kit 1 Kit
200-620-HRH Mouse Anti-Her2 Protein (ECD) ELISA kit for Her2 vaccine, 96 tests, Quantitative Kit 1 Kit
200-630-HRM Mouse Anti-Her2 Protein (ECD) IgM ELISA kit for Her2 vaccine, 96 tests, Quantitative Kit 1 Kit
200-640-HRH Human Anti-Her2 vaccine (E75-peptide) IgG ELISA kit, 96 tests, Quantitative Kit 1 Kit
200-650-HRM Human Anti-Her2 vaccine (E75-peptide) IgM ELISA kit, 96 tests, Quantitative Kit 1 Kit
200-660-HRH Mouse Anti-Her2 vaccine (E75-peptide) IgG ELISA kit, 96 tests, Quantitative Kit 1 Kit
200-670-HRM Mouse Anti-Her2 vaccine (AE37-peptide) IgM ELISA kit, 96 tests, Quantitative Kit 1 Kit
200-700-HRH Human Anti-Her2 vaccine (AE37-peptide) IgG ELISA kit, 96 tests, Quantitative Kit 1 Kit
200-710-HRM Human Anti-Her2 vaccine (AE37-peptide) IgM ELISA kit, 96 tests, Quantitative Kit 1 Kit
200-720-HRH Mouse Anti-Her2 vaccine (AE37-peptide) IgG ELISA kit, 96 tests, Quantitative Kit 1 Kit
200-730-HRM Mouse Anti-Her2 vaccine (AE37-peptide) IgM ELISA kit, 96 tests, Quantitative Kit 1 Kit
200-800-AVG Avastin/Bevacizumab (Anti-VEGF) ELISA Kit for human, 96 tests Kit 1 Kit
200-810-ADG Human Anti-Avastin/Bevacizumab IgG (anti-drug IgG) ELISA Kit for human, 96 tests Kit 1 Kit
200-870-ID24 Avastin/Bevacizumab identification/Counterfeit detection ELISA Kit, 24 tests Kit 1 Kit
CD20-141-R Recombinant Human CD20/MS4A1-mFC fusion Protein (141-184, 44-aa, ECD, rituximab-binding peptide) Recombinant protein 20 ug
CD20-142-P Human CD20/MS4A1 linear peptide (142-184, 43-aa, extracellular domain) rituximab-binding peptide, >95% pure peptide 100 ug
CD20-145-R Recombinant (HEK cells) purified human CD20/MS4A1 (213-297 aa) his tag Protein Recombinant protein 20 ug
CD20-146-R Recombinant (HEK cells) human CD20/MS4A1 (141-184 aa) hFc- fusion Protein Recombinant protein 10 ug
CD20-147-R Recombinant (HEK cells) purified Ferrret CD20/MS4A1 (213-297 aa) his tag Protein Recombinant protein 10 ug
CD20-165-P human CD20/MS4A1 linear peptide (165-184, 20-aa, extracellular domain) broad reactivity with CD20-specific antibodies peptide 100 ug
CD20-1731-P Human CD20/MS4A1 peptide (Acetyl-cPYaNPSLc, 9-aa, Cyclic Cys1-Cys9); contains ANPS motif and reactivity with Rituximab cyclic peptide 100 ug
CD20-1732-P Human CD20/MS4A1 cylcic peptide (Acetyl-cWAANPSMAc, 11 aa, Cys1-Cys11); contains the ANPS motif and avidity for rituximab cyclic peptide 100 ug
CD20-1733-P Human CD20/MS4A1 cyclic peptide (Acetyl-cPYsNPSLc; 9aa, Cys1-Cys9; contains NPS motif and react with rituximab cyclic peptide 100 ug
CD20-182-P Human CD20/MS4A1 linear peptide (CWWEWTIGC, 9-aa) contains motif WEWTI of human CD-20 for rtiuximab peptide 100 ug
CD20-21-M Monoclonal Anti-Human CD20/MS4A1 peptide (EC-domain, rituximab binding) ascites Antibodies 100 ul
CD20-22-A Anti-Human CD20/MS4A1 peptide (EC-domain, rituximab binding domain) IgG, aff pure Antibodies 100 ul
CD20-22-P Anti-Human CD20/MS4A1 control/blocking peptide (EC-domain, rituximab binding domain) Antibodies 100 ug
CD20-23-M Humanized (chimeric) Anti-Human CD20/MS4A1 IgG (rituximab biosimilar), pure Antibodies 100 ul
CD20-RP1L-P CD20/MS4A1 linear peptide (WPRWLEN, 7-aa) contains motif WPXWLE, 6-aa; Rp1L-1) and reacts with rituximab peptide 100 ug
CD20-RP5L-P CD20/MS4A1 linear peptide (QDKLTQWPKWLEg, 13-aa) contains WPXWLE motif and reacts with rituximab peptide 100 ug
HER2-369-A Anti-HER2 peptide IgG (cyclic 367-37; E75 vaccine candidate) Aff pure Antibodies 100 ul
HER2-597-A Anti-HER2 peptide IgG (cyclic 597-626 vaccine candidate) Aff pure Antibodies 100 u
HER21-R-10 Recombinant (HEK) human Her2/Erbb2/Neu (1-652)-hIgG-Fc fusion protein   10 ug
HER22-R-5 Recombinant (sf9) human Her2/Erbb2/Neu (676-1255)-GST fusion protein   5 ug
HER23-R-10 Recombinant (HEK) human Her2/Erbb2/Neu (1-652)-his tag fusion protein   10 ug
HER24-R-10 Recombinant (HEK) mouse Her2/Erbb2/Neu (1-653)-his tag fusion protein   10 ug
HER25-R-10 HER2/ErB2 recombinant protein (1-652, extracellular domain), Human (E. coli)   10 ug
HER26-R-10 Recombinant (HEK) rat Her2/Erbb2/Neu (4-656)-his tag fusion protein   10 ug
HER27-R-10 Recombinant (HEK) rat Her2/Erbb2/Neu (4-656)-his tag fusion protein   10 ug
HER28-R-10 Recombinant (HEK) rat Her2/Erbb2/Neu (4-656)-hIgG1-Fc fusion protein   10 ug
HER29-R-10 Recombinant (HEK) monkey/rhesus Her2/Erbb2/Neu (1-652)-his tag fusion protein   10 ug
HER30-R-10 Recombinant (HEK) monkey/rhesus Her2/Erbb2/Neu (1-652)-hIgG1-Fc fusion protein   10 ug
HER31-M Rabbit mono anti-human Her2/Erbb2/Neu (1-652) protein IgG   100 ul
HER32-A Anti-human Her2/Erbb2/Neu (1-652) protein IgG   100 ul
HER33-M Mouse mono anti-monkey/rhesus Her2/Erbb2/Neu (1-652) protein IgG   100 ul
HER34-A Anti-monkey/rhesus Her2/Erbb2/Neu (1-652) protein IgG   100 ul
RP1L-P CD20/MS4A1 linear peptide (WPRWLEN, 7-aa) contains motif WPXWLE, 6-aa; Rp1L-1) and reacts with rituximab peptide 100 ug
RP5L-P CD20/MS4A1 linear peptide (QDKLTQWPKWLEg, 13-aa) contains WPXWLE motif and reacts with rituximab peptide 100 ug
SM-101000-5 EGFR/HER2 kinase inhibitor (>99%, M.wt 485.94) (Afatinib/BIBW-2992 Chemical 5 mg
SM-101000-50 EGFR/HER2 kinase inhibitor (>99%, M.wt 485.94) (Afatinib/BIBW-2992 Chemical 50 mg
SM-101010-5 Inhibitor of EGFR/HER family (Her1, Her2, Her3 or Pan Her-inhibitor) (BMS-59926/AC480, Mol wt 567.01, >99%) Chemical 5 mg
SM-101010-50 Inhibitor of EGFR/HER family (Her1, Her2, Her3 or Pan Her-inhibitor) (BMS-59926/AC480, Mol wt 567.01, >99%) Chemical 50 mg
SM-101020-10 Inhibitor of EGFR/HDAC/Her2 (CUDC-101; 7-((4-((3-ethynylphenyl)amino)-7-methoxyquinazolin-6-yl)oxy)-N-hydroxyheptanamide, Mol wt 434.49, >99%) Chemical 10 mg
SM-101020-50 Inhibitor of EGFR/HDAC/Her2 (CUDC-101; 7-((4-((3-ethynylphenyl)amino)-7-methoxyquinazolin-6-yl)oxy)-N-hydroxyheptanamide, Mol wt 434.49, >99%) Chemical 50 mg
SM-101030-100 Lapatinib, Inhibitor of Her2/EGFR (IC50=10 nM; mol wt 581; >98%) Chemical 100 mg
SM-101030-25 Lapatinib, Inhibitor of Her2/EGFR (IC50=10 nM; mol wt 581; >98%) Chemical 25 mg
SM-101040-25 Cell permeable Inhibitor of EGFR/ERB family/Her2 (Neratinib/HKI-272, mol wt 557.04; >98%) Chemical 25 mg
SM-101040-5 Cell permeable Inhibitor of EGFR/ERB family/Her2 (Neratinib/HKI-272, mol wt 557.04; >98%) Chemical 5 mg
SM-101050-10 Cell permeable Inhibitor of EGFR2/FGFR/PDGFr/JAK1/Her2 ((E)-4-((4-)1H-1,2,3-Triazol-1-yl)butyl)phenoxy)methyl)-2-(4-trifluoromethyl)oxazole, mol wt 468; >98%) Chemical 10 mg
SM-101050-100 Cell permeable Inhibitor of EGFR2/FGFR/PDGFr/JAK1/Her2 ((E)-4-((4-)1H-1,2,3-Triazol-1-yl)butyl)phenoxy)methyl)-2-(4-trifluoromethyl)oxazole, mol wt 468; >98%) Chemical 100 mg
SM-101060-100 Lapatinib Ditosylate (GW572016, GW2016, Tykerb, Tyverb), Autophos. Inhibitor of Her2/Erb2 (mol wt 925; >98%) Chemical 100 mg
SM-101060-25 Lapatinib Ditosylate (GW572016, GW2016, Tykerb, Tyverb), Autophos. Inhibitor of Her2/Erb2 (mol wt 925; >98%) Chemical 25 mg
SM-101070-10 Canertinib (CI-1033), kinase Inhibitor of Her2/Erb2/EGFR (mol wt 485; >98%) Chemical 10 mg
SM-101070-50 Canertinib (CI-1033), kinase Inhibitor of Her2/Erb2/EGFR (mol wt 485; >98%) Chemical 50 mg
SM-101080-25 CP-724,714, Potent and selective Inhibitor of Her2/Erb2 (mol wt 469; >98%) Chemical 25 mg
SM-101080-5 CP-724,714, Potent and selective Inhibitor of Her2/Erb2 (mol wt 469; >98%) Chemical 5 mg
SM-101090-25 AZD8931, reversible and competitive Inhibitor of Her2/Erbb2/ErbB3 (mol wt 473; >98%) Chemical 5 mg
SM-101090-5 AZD8931, reversible and competitive Inhibitor of Her2/Erbb2/ErbB3 (mol wt 473; >98%) Chemical 5 mg
SM-101100-25 AEE788 (NVP-AEE788), dual Inhibitor of Her2/Erbb2/EGFR (mol wt 440; >98%) Chemical 25 mg
SM-101100-5 AEE788 (NVP-AEE788), dual Inhibitor of Her2/Erbb2/EGFR (mol wt 440; >98%) Chemical 5 mg
SM-101110-10 Mubritinib (TAK-165), potent Inhibitor of Her2/Erbb2 (IC50=6 nm; mol wt 468; >98%) Chemical 10 mg
SM-101110-50 Mubritinib (TAK-165), potent Inhibitor of Her2/Erbb2 (IC50=6 nm; mol wt 468; >98%) Chemical 50 mg
SM-101120-25 Arry-380, Oral, potent Inhibitor of Her2/Erbb2 Tyr kinase (IC50=8 nM; mol wt 869; >98%) Chemical 25 mg
SM-101120-5 Arry-380, Oral, potent Inhibitor of Her2/Erbb2 Tyr kinase (IC50=8 nM; mol wt 869; >98%) Chemical 5 mg
SM-101130-25 Tak-285, dual Inhibitor of Her2/EGFR Tyr kinase (IC50=17 nM; mol wt 547; >98%) Chemical 25 mg
SM-101130-5 Tak-285, dual Inhibitor of Her2/EGFR Tyr kinase (IC50=17 nM; mol wt 547; >98%) Chemical 5 mg